# MedImmune Ventures: portfolio, investments and team

> MedImmune Ventures is a corporate vc based in United States. 46 investments on record, latest Apr 2018. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/medimmune-ventures (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# MedImmune Ventures

Last cheque observed Apr 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Quiet Corporate VC

Series B Series A Series C Fitness Health Care

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 46 on record

Since the last cheque **3106** days **00** hrs **00** min **00** sec

Median round **$60M** Rounds led **0 of 46** Sole investor **1 rounds** Exits **6 from the portfolio** Mostly in **United States, 97%**

Pitch MedImmune Ventures

## MedImmune Ventures highlights

- 01 46 rounds on record
- 02 Mostly Series B and Series A: 60% of its rounds
- 03 Sole investor in 1 rounds, median $22M
- 04 6 exits from the portfolio

## What they do

- **Type:** Corporate VC (from a list, unverified)
- **Cheque size:** Not stated
- **Sectors:** Fitness Health Care
- **Based in:** United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **46 appearances**

- **2018** 1 round
- **Apr** **[Corvidia](https://millionrounds.com/company/corvidia)** Series B · US · FinSMEs **$60M** With 8 others
- **2015** 1 round
- **Feb** **[G1 Therapeutics, Inc.](https://millionrounds.com/company/g1-therapeutics-inc)** Series B · US **$33M** With 5 others
- **2014** 2 rounds
- **Nov** **[MdBio Foundation](https://millionrounds.com/company/mdbio-foundation)** Grant · US **$500K** With 1 other
- **Sept** **[VentiRx Pharmaceuticals](https://millionrounds.com/company/ventirx-pharmaceuticals)** Series B · US **$51M** With 4 others
- **2013** 5 rounds
- **Nov** **[Catabasis Pharmaceuticals](https://millionrounds.com/company/catabasis-pharmaceuticals)** Series B · US · finsmes.com **$32M** With 4 others
- **Oct** **[G1 Therapeutics, Inc.](https://millionrounds.com/company/g1-therapeutics-inc)** Series A · US · finsmes.com **$13M** With 2 others
- **Oct** **[ADC Therapeutics](https://millionrounds.com/company/adc-therapeutics)** Venture · SZ · unquote.com **$40M** With 1 other
- **Sept** **[Inotek Pharmaceuticals](https://millionrounds.com/company/inotek-pharmaceuticals)** Debt · US · inotekcorp.com **$7.0M** With 5 others
- **Feb** **[Catabasis Pharmaceuticals](https://millionrounds.com/company/catabasis-pharmaceuticals)** Venture · US · fiercebiotech.com **$9.0M** With 3 others
- **2012** 3 rounds
- **Nov** **[Applied Genetics Technologies Corporation](https://millionrounds.com/company/applied-genetics-technologies-corporation)** Series B · US · biospace.com **$38M** With 5 others
- **Nov** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Venture · US · phx.corporate-ir.net **$50M** With 8 others
- **Jul** **[Coferon](https://millionrounds.com/company/coferon)** Series B · US · marketwire.com **$12M** With 2 others
- **2011** 3 rounds
- **Dec** **[Catabasis Pharmaceuticals](https://millionrounds.com/company/catabasis-pharmaceuticals)** Series A · US · catabasispharma.com **$8.0M** With 3 others
- **Jul** **[Inotek Pharmaceuticals](https://millionrounds.com/company/inotek-pharmaceuticals)** Series D · US · sec.gov **$24M** With 4 others
- **Jun** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Series D · US · phx.corporate-ir.net **$30M** With 9 others
- **2010** 3 rounds
- **Jun** **[Corridor Pharmaceuticals](https://millionrounds.com/company/corridor-pharmaceuticals)** Series A · US · finance.yahoo.com **$13M** With 7 others
- **Apr** **[Catabasis Pharmaceuticals](https://millionrounds.com/company/catabasis-pharmaceuticals)** Series A · US · fiercebiotech.com **$39M** With 3 others
- **Jan** **[VentiRx Pharmaceuticals](https://millionrounds.com/company/ventirx-pharmaceuticals)** Series A · US · fis.dowjones.com **$25M** With 3 others
- **2009** 8 rounds
- **Nov** **[Virdante Pharmaceuticals](https://millionrounds.com/company/virdante-pharmaceuticals)** Series A · US · onbiovc.com **$30M** With 6 others
- **Oct** **[Corridor Pharmaceuticals](https://millionrounds.com/company/corridor-pharmaceuticals)** Series A · US · venturedeal.com **$11M** With 3 others
- **Aug** **[LigoCyte Pharmaceuticals](https://millionrounds.com/company/ligocyte-pharmaceuticals)** Series C · US **$29M** With 3 others
- **Jun** **[VaxInnate](https://millionrounds.com/company/vaxinnate)** Series D · US · onbiovc.com **$30M** With 6 others
- **Jun** **[Applied Genetics Technologies Corporation](https://millionrounds.com/company/applied-genetics-technologies-corporation)** Series C · US · onbiovc.com **$12M** With 2 others
- **Mar** **[NKT Therapeutics](https://millionrounds.com/company/nkt-therapeutics)** Series A · US · bizjournals.com **$8.0M** With 1 other
- **Jan** **[Melinta](https://millionrounds.com/company/melinta)** Growth · US · rib-x.com **$25M** With 7 others
- **Jan** **[Hydra Biosciences](https://millionrounds.com/company/hydra-biosciences)** Series D · US · reuters.com **$22M** Sole investor
- **2008** 4 rounds
- **Oct** **[Corridor Pharmaceuticals](https://millionrounds.com/company/corridor-pharmaceuticals)** Seed · US · findarticles.com **$2.3M** With 3 others
- **Oct** Seed · findarticles.com **$2.3M** With 3 others
- **Apr** **[LigoCyte Pharmaceuticals](https://millionrounds.com/company/ligocyte-pharmaceuticals)** Series B · US **$28M** With 3 others
- **Mar** **[BrainCells](https://millionrounds.com/company/braincells)** Series B · US · venturebeat.com **$30M** With 5 others
- **2007** 4 rounds
- **Nov** **[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Series D · US **$49M** With 11 others
- **Oct** **[Altiris Therapeutics](https://millionrounds.com/company/altiris-therapeutics)** Series B · US **$35M** With 8 others
- **Aug** **[Inotek Pharmaceuticals](https://millionrounds.com/company/inotek-pharmaceuticals)** Series C · US **$19M** With 4 others
- **Jan** **[Sequoia Pharmaceuticals](https://millionrounds.com/company/sequoia-pharmaceuticals)** Series C · US · fiercebiotech.com **$35M** With 4 others
- **2006** 4 rounds
- **Oct** **[VaxInnate](https://millionrounds.com/company/vaxinnate)** Series C · US · thefreelibrary.com **$40M** With 5 others
- **Aug** Series A · highbeam.com **$4.5M** With 20 others
- **Jun** **[VLST Corporation](https://millionrounds.com/company/vlst-corporation)** Series B · US · vlstcorp.com **$55M** With 6 others
- **May** **[Avidia](https://millionrounds.com/company/avidia)** Series C · US · freshnews.com **$44M** With 6 others
- **2005** 2 rounds
- **May** **[Avidia](https://millionrounds.com/company/avidia)** Series B · US · thefreelibrary.com **$29M** With 1 other
- **Apr** **[Receptor Biologix](https://millionrounds.com/company/receptor-biologix)** Series A **$34M** With 5 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## Exits from the portfolio

Companies it backed that were later bought or listed **6 in all**

**[Ambit Biosciences](https://millionrounds.com/company/ambit-biosciences)** Bought by [Daiichi Sankyo](https://millionrounds.com/fund/daiichi-sankyo) **$410M** Sept 2014

**[LigoCyte Pharmaceuticals](https://millionrounds.com/company/ligocyte-pharmaceuticals)** Bought by [Takeda Pharmaceutical](https://millionrounds.com/fund/takeda-pharmaceutical) **$60M** Oct 2012

**[Avidia](https://millionrounds.com/company/avidia)** Bought by [Amgen](https://millionrounds.com/fund/amgen) **$290M** Sept 2008

**[Tercica](https://millionrounds.com/company/tercica)** Bought by [Ipsen](https://millionrounds.com/fund/ipsen) **$480M** Jun 2008

**[Iomai Corporation](https://millionrounds.com/company/iomai-corporation)** Bought by Intercell **$186M** May 2008

**[Critical Therapeutics,Inc.](https://millionrounds.com/company/critical-therapeutics-inc)** Bought by Cornerstone Therapeutics **Undisclosed** May 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Series B Series A Series C

Median round joined **$60M** the round, not its cheque Alone, median **$22M**

Led 0 of 46 rounds **0%**

- **Sole investor:** 1 rounds
- **Last cheque:** Apr 2018
- **Exits:** 6 from the portfolio

Rounds by stage said on their site

- Series B *15*
- Series A *11*
- Series C *7*
- Series D *5*
- Venture *3*
- Seed *2*

Cheques by year Led Joined

2003 2018

Often in the room with

- [HealthCare Ventures](https://millionrounds.com/fund/healthcare-ventures-llc) 6
- [Oxford Bioscience Partners](https://millionrounds.com/fund/oxford-bioscience-partners) 6
- [Advanced Technology Ventures](https://millionrounds.com/fund/advanced-technology-ventures) 5
- [Care Capital](https://millionrounds.com/fund/care-capital) 5
- [Clarus Ventures](https://millionrounds.com/fund/blackstone) 5
- [Forward Ventures](https://millionrounds.com/fund/forward-ventures) 5

**Pitching MedImmune Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as MedImmune Ventures. A count of rooms they were both in, not a relationship either has claimed.

[**HealthCare Ventures** Growth equity **6** rounds together](https://millionrounds.com/fund/healthcare-ventures-llc)[**Oxford Bioscience Partners** Growth equity **6** rounds together](https://millionrounds.com/fund/oxford-bioscience-partners)[**Advanced Technology Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/advanced-technology-ventures)[**Care Capital** Growth equity **5** rounds together](https://millionrounds.com/fund/care-capital)[**Clarus Ventures** VC firm **5** rounds together](https://millionrounds.com/fund/blackstone)[**Forward Ventures** Accelerator **5** rounds together](https://millionrounds.com/fund/forward-ventures)[**Quaker Partners** VC firm **5** rounds together](https://millionrounds.com/fund/quaker-partners)[**Red Abbey Venture Partners** VC firm **5** rounds together](https://millionrounds.com/fund/red-abbey-venture-partners)[**SV Life Sciences** VC firm **5** rounds together](https://millionrounds.com/fund/sv-life-sciences)[**Acidophil** VC firm **4** rounds together](https://millionrounds.com/fund/acidophil)[**Domain Associates** VC firm **4** rounds together](https://millionrounds.com/fund/domain-associates)[**Rho Capital Partners** Private equity **4** rounds together](https://millionrounds.com/fund/rho-capital-partners)

## Quick answers about MedImmune Ventures

### What does MedImmune Ventures invest in?

MedImmune Ventures invests most often at Series B and Series A (60% of the rounds on record), in sectors such as Fitness and Health Care.

### How active is MedImmune Ventures?

46 investments on record, 0 of them in the last 12 months. The most recent was in Apr 2018.

### What has MedImmune Ventures invested in recently?

Its most recent investments on record: Corvidia (Series B, Apr 2018).

### How big are MedImmune Ventures's cheques?

The median round it joins is $60M.

### Does MedImmune Ventures lead rounds?

Rarely, if at all: none of its 46 investments on record names it as the lead.

### Where does MedImmune Ventures invest?

Most of the companies it backs are in the United States (97%).

### Is MedImmune Ventures investing now?

No investments in the last 12 months; the latest was in Apr 2018.

### Who does MedImmune Ventures invest alongside?

Most often HealthCare Ventures (6 rounds together), Oxford Bioscience Partners (6 rounds together) and Advanced Technology Ventures (5 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=medimmune-ventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=medimmune-ventures)